Identifying novel biomarkers for cardiovascular disease risk prediction.

Ge Y, Wang TJ
J Intern Med. 2012 272 (5): 430-9

PMID: 22950687 · DOI:10.1111/j.1365-2796.2012.02589.x

The primary prevention of cardiovascular disease relies on the ability to identify at-risk individuals long before the development of overt events. In the past decade, research into circulating, genetic and imaging biomarkers to augment traditional methods of risk prediction has only achieved modest success. Emerging technologies in the fields of genomics, metabolomics and proteomics are providing new platforms for biomarker discovery. Here, we review current concepts in the evaluation and discovery of cardiovascular biomarkers. Further research is needed to identify new biomarkers to successfully stratify risk of cardiovascular disease in low-risk populations, as well as to test whether management strategies informed by biomarker testing are better than standard of care.

© 2012 The Association for the Publication of the Journal of Internal Medicine.

MeSH Terms (9)

Biomarkers Cardiovascular Diseases Genomics Genomics Humans Metabolomics Primary Prevention Proteomics Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: